India Levetiracetam market is expected
to grow at a significant rate during the forecast period. Levetiracetam drug is
sold under the brand name Keppra, which is generally used to treat epilepsy by
decreasing abnormal excitement in the brain. The India levetiracetam market is
driven by use of this drug to treat partial onset seizures in adults and
children who are at least 1 month old. Moreover, high incidence of epilepsy in
India is forecasted to positively influence the market growth. Large number of
clinical trials by key market players is further expected to boost the growth
of India levetiracetam market through FY2027.
The India levetiracetam market is
segmented based on source, form, distribution channel, treatment, route of administration, company, and region. Based on treatment,
the market can be segmented into myoclonic treatment, tonic-clonic seizures
treatment and others. Among these, myoclonic treatment segment is through FY2027
on account of growing prevalence of myoclonic epilepsy in the country.
Moreover, the drug is effective for treating generalized tonic-clonic epilepsy,
which is further boosting the segmental growth.
The major players operating in the India
levetiracetam market are IPCA Laboratories Ltd., UCB India Pvt. Ltd., Cipla
Limited, Ranbaxy Laboratories Ltd., Torrent Pharmaceuticals Ltd., Unichem
Laboratories Ltd., Anuh Pharma Ltd., SVK Laboratories Private Limited, Jubilant
Life Sciences Limited, Carise Phamaceuticals Pvt. Ltd., and others. Major
companies are developing
advanced technologies and launching new products in order to stay competitive
in the market. Other competitive strategies include mergers & acquisitions,
research collaborations and new product developments to expand their geographic
reach and to increase their customer basis.
Years
considered for this report:
Historical Years: FY2017-FY2020
Base Year: FY2021
Estimated Year: FY2022
Forecast
Period: FY2023–FY2027
Objective of the Study:
- To analyze and estimate the market size of India levetiracetam market
from FY2017 to FY2020.
- To estimate and forecast the market size of India levetiracetam market
from FY2021 to FY2027 and growth rate until FY2027.
- To classify and forecast India levetiracetam market based on
source, form, distribution channel, treatment, route of administration,
company, and regional distribution.
- To identify dominant region or segment in the India levetiracetam market.
- To identify drivers and challenges for India levetiracetam market.
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in India levetiracetam market.
- To identify and analyze the profile of leading players operating in
India levetiracetam market.
- To identify key sustainable strategies adopted by market players in
India levetiracetam market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of manufacturers across the globe. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufacturers which could not be identified
due to the limitations of secondary research. TechSci Research analyzed the
manufacturers, distribution channels and presence of all major players across
the globe.
TechSci
Research calculated the market size of India levetiracetam market using a bottom-up approach, wherein data for various end-user segments
was recorded and forecast for the future years. TechSci Research sourced these
values from the industry experts and company representatives and externally
validated through analyzing historical data of these product types and
applications for getting an appropriate, overall market size. Various secondary
sources such as company websites, news articles, press releases, company annual
reports, investor presentations and financial reports were also studied by
TechSci Research.
Key Target Audience:
- Levetiracetam manufacturers/ suppliers/
distributors
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums and alliances related to
levetiracetam
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as manufacturers,
suppliers and partners, end users, etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
Report Scope:
In this report, India levetiracetam market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Levetiracetam Market, By Source:
- In-house
- Contract
Manufacturing Organizations
- India Levetiracetam Market, By Form:
- India Levetiracetam Market, By Distribution Channel:
- India Levetiracetam Market, By Treatment:
- Myoclonic
Treatment
- Tonic-Clonic
Seizures Treatment
- Others
- India Levetiracetam Market, By Route of Administration:
- India Levetiracetam Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India levetiracetam market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
India levetiracetam market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]